Merck & Company Inc (MRK)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 19,920,000 13,705,000 15,234,000 3,896,000 1,877,000 7,435,000 5,398,000 15,218,000 16,436,000 16,767,000 18,451,000 16,017,000 14,570,000 8,702,000 6,761,000 8,111,000 8,532,000 13,219,000 12,239,000 12,126,000
Revenue (ttm) US$ in thousands 64,168,000 63,174,000 62,479,000 61,402,000 60,114,000 59,314,000 58,311,000 57,869,000 59,283,000 58,974,000 57,169,000 53,978,000 48,704,000 46,131,000 43,906,000 41,857,000 43,287,000 36,488,000 37,956,000 40,363,000
Pretax margin 31.04% 21.69% 24.38% 6.35% 3.12% 12.53% 9.26% 26.30% 27.72% 28.43% 32.27% 29.67% 29.92% 18.86% 15.40% 19.38% 19.71% 36.23% 32.25% 30.04%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $19,920,000K ÷ $64,168,000K
= 31.04%

The pretax margin of Merck & Company Inc has displayed fluctuations over the period from March 31, 2020, to December 31, 2024. Initially starting at 30.04% in March 2020, the pretax margin increased to its peak at 36.23% by September 30, 2020. However, by December 31, 2020, there was a significant decline to 19.71%.

Throughout 2021 and the first half of 2022, the pretax margin remained relatively stable, hovering around the mid to high 20% range. There was a notable decrease to 9.26% by June 30, 2023, before a slight recovery to 24.38% by June 30, 2024.

In the latter part of 2024, the pretax margin for Merck & Company Inc rose to 31.04% by December 31, 2024. Overall, the pretax margin trend of the company reflects periods of both growth and decline, indicating fluctuations in profitability before a recent improvement towards the end of 2024.